Frontage Holdings (1521 HK)

Analysis

Health Care • United States

Frontage Holdings is a contract research organization (CRO) providing integrated, scientifically-driven research, analytical, and development services to pharmaceutical, biotech, and agrochemical companies. Its services span drug discovery, preclinical and clinical development, including DMPK, safety and toxicology, bioanalysis, and GMP manufacturing. The company was founded in 2001 and is headquartered in Exton, PA, USA.

Refresh

Exchange Announcement • 22 Sep 2026 16:40

Notification Letter And Request Form For Non-Registered Shareholders

Exchange Announcement • 22 Sep 2026 16:36

Notification Letter And Reply Form For Registered Shareholders

Exchange Announcement • 22 Sep 2026 16:32

2026 Interim Report

Exchange Announcement • 28 Aug 2026 17:30

Announcement On Interim Results For The Six Months Ended June 30, 2026

Exchange Announcement • 17 Aug 2026 16:33

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Notification Letter And Request Form For Non-Registered Shareholders

Notification Letter And Reply Form For Registered Shareholders

2026 Interim Report

Announcement On Interim Results For The Six Months Ended June 30, 2026

Date Of Board Meeting